NYAS Conferences
New York Academy of Sciences
left end
Search
divider divider feedback right end
Annals of the New York Academy of Sciences Annals of the New York Academy of Sciences login

Main

Browse Volumes

Forthcoming Volumes

Annals PrePrints

Annals Extra

E-mail Alerts

Subscriptions & Orders

New Proposals

Author Guidelines

About Annals

Help

Get free Annals volume as a NYAS member: http://www.nyas.org/annalsreaderhw
Issue 955 coverENDOMETRIOSIS: EMERGING RESEARCH AND INTERVENTION STRATEGIES Copyright © 2002 by the New York Academy of Sciences
description

This Volume
Table of Contents
Description
This Article
Full Text
Full Text (PDF)
Services
Similar articles in this journal
Similar articles in PubMed
Alert me to new issues of the journal
Download to citation manager
Citing Articles
Citing Articles via HighWire
Citing Articles via Google Scholar
Google Scholar
Articles by SIDELL, N.
Articles by PARTHASARATHY, S.
Search for Related Content
PubMed
PubMed Citation
Articles by SIDELL, N.
Articles by PARTHASARATHY, S.
Annals of the New York Academy of Sciences 955:159-173 (2002)
© 2002 New York Academy of Sciences

Regulation and Modulation of Abnormal Immune Responses in Endometriosis

NEIL SIDELL, SHOU WEI HAN AND SAMPATH PARTHASARATHY

Department of Gynecology and Obstetrics, Emory Center for Advanced Research on Women's Health, Emory University, Atlanta, Georgia 30322, USA

Address for correspondence: Neil Sidell, Ph.D., Department of Gynecology and Obstetrics, 4303 Woodruff Memorial Research Building, 1639 Pierce Drive, Emory University School of Medicine, Atlanta, GA 30322. Voice: 404-727-9155; fax: 404-727-8615.
nsidell{at}emory.edu

There is ample evidence demonstrating that endometriosis is accompanied by inflammatory reactions in the peritoneum, resulting in abnormal levels of a variety of cytokines and chemokines in the peritoneal fluid. Among the immunological parameters that have been shown to be altered in the peritoneal cavity of women with endometriosis, an increase in the number of activated nonadherent macrophages that show reduced surface expression of scavenger receptors has been observed. The cause-and-effect relationship between aberrant peritoneal macrophage activity and endometriosis is still unknown. We have demonstrated that steroid hormone receptor agonists and antagonists [e.g., retinoids, antiglucocorticoids, ligands to peroxisome proliferator activated receptors (PPARs)] can regulate macrophage functions in ways that could either suppress or stimulate the growth of ectopic endometrial lesions. Our studies include a number of relevant findings: (1) RU486, acting as an antioxidant, can suppress activation of NF{kappa}B, a nuclear transcription factor that affects the expression of several inflammatory genes such as those for MCP-1, GM-CSF, CSF-1, and various adhesion molecules; (2) IL-6 secretion from a variety of cell types including endometrial cells is inhibited by retinoic acid; and (3) retinoids and PPAR{gamma} ligands can upregulate the expression of scavenger receptors in cells of the monocyte/macrophage lineage. These observations, combined with the possibility that macrophage activity may play a fundamental role in endometriosis, suggest that pharmacologic manipulation of macrophage function may provide a novel mechanism for treating this disease.

Key Words: endometriosis • PPAR{gamma} • RU486 • IL-6 • CD36 • scavenger receptor • monocytes




This article has been cited by other articles:


Home page
Stem CellsHome page
H. Du and H. S. Taylor
Contribution of Bone Marrow-Derived Stem Cells to Endometrium and Endometriosis
Stem Cells, August 1, 2007; 25(8): 2082 - 2086.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
R. Gonzalez-Ramos, J. Donnez, S. Defrere, I. Leclercq, J. Squifflet, J.-C. Lousse, and A. Van Langendonckt
Nuclear factor-kappa B is constitutively activated in peritoneal endometriosis
Mol. Hum. Reprod., July 1, 2007; 13(7): 503 - 509.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
S. Matsuzaki, M. Canis, J.-L. Pouly, R. Botchorishvili, P.J. Dechelotte, and G. Mage
Both GnRH agonist and continuous oral progestin treatments reduce the expression of the tyrosine kinase receptor B and mu-opioid receptor in deep infiltrating endometriosis
Hum. Reprod., January 1, 2007; 22(1): 124 - 128.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. K. Tee, J.-L. Vigne, and R. N. Taylor
All-Trans Retinoic Acid Inhibits Vascular Endothelial Growth Factor Expression in a Cell Model of Neutrophil Activation
Endocrinology, March 1, 2006; 147(3): 1264 - 1270.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
H. S. Taylor
Endometrial Cells Derived From Donor Stem Cells in Bone Marrow Transplant Recipients
JAMA, July 7, 2004; 292(1): 81 - 85.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
G. F. Meresman, M. A. Bilotas, E. Lombardi, M. Tesone, C. Sueldo, and R. I. Baranao
Effect of GnRH analogues on apoptosis and release of interleukin-1{beta} and vascular endothelial growth factor in endometrial cell cultures from patients with endometriosis
Hum. Reprod., September 1, 2003; 18(9): 1767 - 1771.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Han and N. Sidell
RU486-Induced Growth Inhibition of Human Endometrial Cells Involves the Nuclear Factor-{kappa}B Signaling Pathway
J. Clin. Endocrinol. Metab., February 1, 2003; 88(2): 713 - 719.
[Abstract] [Full Text] [PDF]



footerLeft footerRight